We are live on ! Find out more
ITOS

iTeos Therapeutics
ITOS

Delisted

ITOS was delisted on the 28th of August, 2025.

Back to rankings

118 hedge funds and large institutions have $1.55B invested in iTeos Therapeutics in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,050% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 4

85% more capital invested

Capital invested by funds: $841M → $1.55B (+$712M)

75% more funds holding in top 10

Funds holding in top 10: 4 → 7 (+3)

54% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 24

53% more funds holding

Funds holding: 77 → 118 (+41)

6.23% more ownership

Funds ownership: 88.47% → 94.71% (+6.2%)

Holders
118
Holders Change
+41
Holders Change %
+53.25%
% of All Funds
1.82%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.11%
New
46
Increased
37
Reduced
24
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OCA
Octagon Capital Advisors
New York
+$15M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$14.7M
3
State Street
State Street
Massachusetts
+$14.7M
4
CS
Candriam SCA
Luxembourg
+$7.73M
5
Millennium Management
Millennium Management
New York
+$7.57M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$15M
2
MAM
MPM Asset Management
Massachusetts
-$13.5M
3
MB
MPM BioImpact
Massachusetts
-$8.73M
4
Citigroup
Citigroup
New York
-$6.82M
5
SAM
Sectoral Asset Management
Quebec, Canada
-$6.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
26
Adage Capital Partners
Massachusetts
$7.92M +$2.5M +75,000 +79%
Morgan Stanley
27
Morgan Stanley
New York
$7.64M +$246K +7,391 +5%
N
28
Nuveen
North Carolina
$7.11M +$2.76M +82,799 +78%
BBA
29
Baker Bros. Advisors
New York
$7M – – –
CAM
30
Cormorant Asset Management
Massachusetts
$6.98M -$4.6M -138,330 -48%
HIM
31
Hillsdale Investment Management
Ontario, Canada
$6.82M +$4.88M +146,500 New
Charles Schwab
32
Charles Schwab
California
$6.64M +$68.5K +2,057 +1%
SCM
33
Silverarc Capital Management
Massachusetts
$6.43M +$702K +21,075 +18%
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$5.96M +$2.64M +79,441 +163%
PPA
35
Parametric Portfolio Associates
Washington
$5.77M +$3.87M +116,238 +1,503%
Goldman Sachs
36
Goldman Sachs
New York
$5.46M -$1.93M -57,980 -33%
Wellington Management Group
37
Wellington Management Group
Massachusetts
$4.97M -$3.88M -116,454 -52%
Point72 Asset Management
38
Point72 Asset Management
Connecticut
$4.89M +$3.5M +105,030 New
ACM
39
Asymmetry Capital Management
California
$4.88M +$1.58M +47,469 +83%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$4.78M +$1.04M +31,154 +44%
Federated Hermes
41
Federated Hermes
Pennsylvania
$4.46M +$3.19M +95,798 New
Bank of America
42
Bank of America
North Carolina
$4.15M +$2.22M +66,694 +298%
ECM
43
ExodusPoint Capital Management
New York
$3.79M +$2.71M +81,511 New
SAM
44
Sectoral Asset Management
Quebec, Canada
$3.73M -$6.45M -193,700 -71%
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$3.58M +$2.56M +76,850 New
EI
46
EAM Investors
California
$3.06M +$2.19M +65,707 New
JP Morgan Chase
47
JP Morgan Chase
New York
$2.73M +$1.47M +44,131 +303%
Prudential Financial
48
Prudential Financial
New Jersey
$2.64M +$1.89M +56,630 New
Allspring Global Investments
49
Allspring Global Investments
North Carolina
$2.63M +$1.88M +56,503 New
DCM
50
DAFNA Capital Management
California
$2.52M -$964K -28,971 -35%
1
2
3 4 5

ITOS Hedge Fund Activity: Q4 2021 in Review

118 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in iTeos Therapeutics (ITOS) for Q4 2021, worth a combined $1.55B — up 85% from $841M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new ITOS positions and 4 closed out — a net gain of 42 holders — while 37 added to existing stakes and 24 trimmed.

The largest buyer was Octagon Capital Advisors, opening a new position worth an estimated $15M. The largest seller was Artal Group, cutting an estimated $15M.

  • 118 institutional investors held iTeos Therapeutics (ITOS) as of Q4 2021, up from 77 in Q3 2021.
  • Funds reported $1.55B of iTeos Therapeutics stock for Q4 2021, up 85% quarter-over-quarter.
  • 46 funds opened new iTeos Therapeutics positions in Q4 2021 and 4 closed out, a net change of +42 holders.
  • The largest iTeos Therapeutics buyer in Q4 2021 was Octagon Capital Advisors, an estimated $15M added.
  • The largest iTeos Therapeutics seller in Q4 2021 was Artal Group, an estimated $15M sold.

Based on aggregated 13F filings for Q4 2021.